A few months I had a hotel and flight booked for San Diego to attend the annual BIO conference and exhibition this week. COVID-19 changed that, and in short order the Biotechnology Innovation Organization moved online and on Monday launched BIO Digital
I have been attending some of the sessions, but with research becoming important right now have had limited time to follow-up with our usual collection of BIORadio podcasts and blog posts, but I have squeezed in a few phone interviews.
would also have busy at the event in San Diego to show off the biotech strength of its 230 members, so one of the interviews I made time for is with Andrew Casey, President and CEO of the organization.
In a 2017 survey (maybe time for a new one?) of life science companies, a majority of them reported revenue of less than one million dollars. However those respondents had high expectations for revenue growth by 2021. Enter the pandemic and the increased need for biotech expertise and innovation.
Here is my conversation with Andrew Casey about where we are now, and what impact the pandemic could have on the growth of the Canada’s biotechnology industry.